Effect of cefazolin and vancomycin on osteoblasts in vitro

Clinical Orthopaedics and Related Research

Volumn 333, Issue , 1996, Pages 245-251

  Edin, Matthew L ^a   Miclau, Theodore ^b,d   Lester, Gayle E ^a   Lindsey, Ronald W ^c   Dahners, Laurence E ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; CANCER CELL CULTURE; CELL DIVISION; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0030454517     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199612000-00027     Document Type: Article

References (46)

1. Andrianarivo AG, Robinson JA, Mann KG, Tracy RP: Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells. J Cell Phys 153: 256-265, 1992.
2. Atkinson BA: Species Incidence and Trends of Susceptibility to Antibiotics in the United States and Other Countries: MIC and MBC. In Atkinson BA (ed). Antibiotics in Laboratory Medicine. Ed 2. Baltimore. Williams and Wilkins 1122-1141, 1986.
3. Baker A, Greenham T: Release of gentamicin from acrylic bone cement: Elution and effusion studies. J Bone Joint Surg 70B:551-1557, 1988.
4. Beeching NJ, Thomas MG, Roberts S, Lang SDR: Comparative in-vitro activity of antibiotics incorporated in acrylic bone cement. J Antimicrob Chem 17:173-184, 1986.
5. 3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG-63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 264:11879-11886, 1982.
6. Buchholz HW, Engelbrecht H: Über die Depotwirkung einiger Antibiotika bei Vermischung unter den Kunstharz Palacos. Chirurg 41:511, 1970.
7. Christian EP, Bosse MJ, Robb G: Reconstruction of large diaphyseal defects, without free fibular transfer, in grade-IIIB tibial fractures. J Bone Joint Surg 71A:994-1004, 1989.
8. Clawson DK, Davis FJ, Hansen ST: Treatment of chronic osteomyelitis with emphasis on closed suction irrigation technique. Clin Orthop 96:88-97, 1973.
9. Dahners LE, Funderburk CH: Gentamycin-loaded plaster of Paris as a treatment of experimental osteomyelitis in rabbits. Clin Orthop 219:278-282, 1987.
10. Dombrowski ET, Dunn AW: Treatment of osteomyelitis by debridement and closed wound irrigation-suction. Clin Orthop 43:215-231, 1965.
11. Fawthrop FW, Oyajobi BO, Bunning RAD, Russel GG: The effect of transforming growth factor β on the plasminogen activator activity of normal human osteoblast-like cells and a human osteosarcoma cell line MG-63. J Bone Miner Res 7:1363-1371, 1992.
12. Fillastre JP, Hemet J, Tulkens P, et al.: Comparative nephrotoxicity of four aminoglycosides: Biochemical and ultrastructural modifications of lysosomes. Adv Nephrol 12:253-275, 1983.
13. 3 specific regulation of growth, morphology, and fibronectin in a human osteosarcoma cell line. J Cell Phys 123:401-409, 1985.
14. 3 in human osteosarcoma cells. J Biol Chem 263:18938-18945, 1988.
15. 3 and ascorbic acid in bone-derived cells. J Bone Miner Res 5:1157-1167, 1990.
16. 2+ incorporation in osteoblast-like cells: Possible involvement of alkaline phosphatase. Endocrinology 126:1941-1949, 1990.
17. Gerhart TN, Roux RD, Horowitz G, et al: Antibiotic release from an experimental biodegradable bone cement. J Orthop Res 6:585-592, 1988.
18. Hughes S, Field CA, Kennedy MRK, Dash CH: Cephalosporins in bone cement. J Bone Joint Surg 61B:96-100, 1979.
19. Klemm K: Antibiotic bead chains. Clin Orthop 295:63-76, 1993.
20. Lajeunesse D, Frondoza C, Schoffield B, Sacktor B: Osteocalcin secretion by the human osteosarcoma cell line MG-63. J Bone Miner Res 5:915-921, 1990.
21. Lajeunesse D, Kiebzak GM, Frondoza C, Sacktor B: Regulation of osteocalcin secretion by human primary bone cells and by the human osteosarcoma cell line MG-63. Bone Mineral 14:237-250, 1991.
22. Lawson KJ, Marks KE, Brems J, Rehm S: Vancomycin vs tobramycin elution from polymethylmethacrylate: An in vitro study. Orthopedics 13:521-524, 1990.
23. Levin PD: The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint Surg 576:234-237, 1975.
24. Long JW, Knight WE: Antibiotic impregnated bone cement in total joint replacement. J Bone Joint Surg 59B:512, 1979 (Abstract).
25. Mackey D, Varlet A, Debeaumont D: Antibiotic loaded plaster of Paris pellets. Clin Orthop 167:263-269, 1982.
26. Mader JT, Cierny G: The principles of the use of preventive antibiotics. Clin Orthop 190:75-82, 1984.
27. Marks KE, Nelson CL, Lautenschlager EP: Antibiotic-impregnated acrylic bone cement. J Bone Joint Surg 58A:358-364, 1976.
28. Mc Laren AC: Antibiotic impregnated bone graft: Post-op levels of vancomycin and tobramycin. J Orthop Trauma 3:171, 1989 (Abstract).
29. Mc Laren AC, Miniaci A: In vivo study to determine the efficacy of cancellous bone graft as a delivery vehicle for antibiotics. Trans Soc Biomater 12:102, 1986.
30. Miclau T, Edin ML, Lester GE, Lindsey RW, Dahners LE: Bone toxicity of locally applied aminoglycosides. J Orthop Trauma 9:401-406, 1995.
31. Murray WR: Use of antibiotic-containing bone cement. Clin Orthop 190:89-95, 1984.
32. Neu HC: Cephalosporin antibiotics as applied in surgery of bones and joints. Clin Orthop 190:50-64, 1984.
33. Perry CR, Davenport K, Vossen MK: Local delivery of antibiotics via an implantable pump in the treatment of osteomyelitis. Clin Orthop 226:222-230, 1988.
34. Perry CR, Pruitt DL: Local antibiotic administration via an implantable pump for the treatment of chronic osteomyelitis. Hosp Formul 23:342-351, 1988.
35. Perry CR, Rice S, Ritterbusch JK, Burdge RE: Local administration of antibiotics with an implantable osmotic pump. Clin Orthop 182:284-290, 1985.
36. Picknell B, Mizen L, Sutherland R: Antibacterial activity of antibiotics in acrylic bone cement. J Bone Joint Surg 596:302-307, 1979.
37. Sande MA, Mandell GL: Antimicrobial Agents. In Goodman TM, Gilman AG (eds). The Pharmacological Basis of Therapeutics. Ed 8. New York, MacMillan 1150-1169, 1985.
38. Seligson D, Mehta S, Voos K, Henry SL, Johnson JR: The use of antibiotic-impregnated polymethylmethacrylate beads to prevent the evolution of localized infection. J Orthop Trauma 6:401-406, 1992.
39. Smilack J, Flittie W, Williams T: Bone concentrations of antimicrobial agents after parenteral administration. Antimicrob Agents Chemother 9:169-171, 1976.
40. Trippel SH: Current concepts in review. Antibiotic impregnated cement in total joint arthroplasty. J Bone Joint Surg 68A: 1297-1302, 1986.
41. Varlet A, Dauchy P: Billes de platre de Paris aux antibiotics dans le traitement de l'infection osseuse. Revue de Chirurgie Orthopedique 69:239-244, 1983.
42. Wahlig H, Dingeldein E: Antibiotics and bone cements. Acta Orthop Scand 51: 49-56, 1980.
43. Wahlig H, Dingeldein E, Bergman R, Reuss K: The release of gentamycin from polymethylmethacrylate. J Bone Joint Surg 608:270-275, 1978.
44. Weeks SM, Dahners LE: A comparative study of the effects of gentamycin wound irrigation versus systemec gentamycin in the treatment of open fracture. Trans 38th Annual Orthop Res Soc 17:438, 1992.
45. Wilde A, Ruth J: Two-stage reimplantation in infected total knee arthroplasty. Clin Orthop 236:23-25, 1988.
46. Willenegger H: Klinik und therapie der pyogenen knocheninfektionen. Chirurg 41:215-221, 1970.